Articoli con mandati relativi all'accesso pubblico - John LallyUlteriori informazioni
Non disponibili pubblicamente: 4
Substance use, medication adherence and outcome one year following a first episode of psychosis
M Colizzi, E Carra, S Fraietta, J Lally, D Quattrone, S Bonaccorso, ...
Schizophrenia research 170 (2-3), 311-317, 2016
Mandati: UK Medical Research Council, National Institute for Health Research, UK
Increased rates of respiratory disease in schizophrenia: A systematic review and meta-analysis including 619,214 individuals with schizophrenia and 52,159,551 controls
S Suetani, F Honarparvar, D Siskind, G Hindley, N Veronese, ...
Schizophrenia Research 237, 131-140, 2021
Mandati: UK Medical Research Council, National Institute for Health Research, UK …
Acute hospital service utilization by inpatients in psychiatric hospitals
J Lally, YL Wong, H Shetty, A Patel, V Srivastava, MTM Broadbent, ...
General Hospital Psychiatry 37 (6), 577-580, 2015
Mandati: National Institute for Health Research, UK
Clozapine rechallenge following neuroleptic malignant syndrome: a systematic review
J Lally, C McCaffrey, C O'Murchu, A Krivoy, A Guerandel, JH MacCabe, ...
Journal of Clinical Psychopharmacology 39 (4), 372-379, 2019
Mandati: National Institute for Health Research, UK
Disponibili pubblicamente: 60
Antipsychotic medication in schizophrenia: a review
J Lally, JH MacCabe
British medical bulletin 114 (1), 169-179, 2015
Mandati: UK Medical Research Council, National Institute for Health Research, UK
Remission and recovery from first-episode psychosis in adults: systematic review and meta-analysis of long-term outcome studies
J Lally, O Ajnakina, B Stubbs, M Cullinane, KC Murphy, F Gaughran, ...
The British Journal of Psychiatry 211 (6), 350-358, 2017
Mandati: UK Medical Research Council, National Institute for Health Research, UK
Two distinct patterns of treatment resistance: clinical predictors of treatment resistance in first-episode schizophrenia spectrum psychoses
J Lally, O Ajnakina, M Di Forti, A Trotta, A Demjaha, A Kolliakou, ...
Psychological medicine 46 (15), 3231-3240, 2016
Mandati: UK Medical Research Council, National Institute for Health Research, UK
Augmentation of clozapine with electroconvulsive therapy in treatment resistant schizophrenia: a systematic review and meta-analysis
J Lally, J Tully, D Robertson, B Stubbs, F Gaughran, JH MacCabe
Schizophrenia research 171 (1-3), 215-224, 2016
Mandati: US National Institutes of Health, National Institute of Health and Medical …
Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial
P Gardner-Sood, J Lally, S Smith, Z Atakan, K Ismail, KE Greenwood, ...
Psychological medicine 45 (12), 2619-2629, 2015
Mandati: National Institute for Health Research, UK
Physical multimorbidity and psychosis: comprehensive cross sectional analysis including 242,952 people across 48 low-and middle-income countries
B Stubbs, A Koyanagi, N Veronese, D Vancampfort, M Solmi, F Gaughran, ...
BMC medicine 14, 1-12, 2016
Mandati: Research Foundation (Flanders), National Institute of Health and Medical …
Prevalence and predictors of clozapine-associated constipation: a systematic review and meta-analysis
A Shirazi, B Stubbs, L Gomez, S Moore, F Gaughran, RJ Flanagan, ...
International Journal of Molecular Sciences 17 (6), 863, 2016
Mandati: UK Medical Research Council, National Institute for Health Research, UK
Vitamin D deficiency in first episode psychosis: a case–control study
M Crews, J Lally, P Gardner-Sood, O Howes, S Bonaccorso, S Smith, ...
Schizophrenia research 150 (2-3), 533-537, 2013
Mandati: UK Medical Research Council
Clinical correlates of vitamin D deficiency in established psychosis
J Lally, P Gardner-Sood, M Firdosi, C Iyegbe, B Stubbs, K Greenwood, ...
BMC psychiatry 16, 1-9, 2016
Mandati: UK Medical Research Council, National Institute for Health Research, UK …
Treatment resistant schizophrenia–review and a call to action
J Lally, F Gaughran
Irish journal of psychological medicine 36 (4), 279-291, 2019
Mandati: National Institute for Health Research, UK
Changes in brain glutamate on switching to clozapine in treatment-resistant schizophrenia
G McQueen, KV Sendt, A Gillespie, A Avila, J Lally, K Vallianatou, ...
Schizophrenia bulletin 47 (3), 662-671, 2021
Mandati: UK Medical Research Council, National Institute for Health Research, UK
Sodium valproate and clozapine induced neutropenia: a case control study using register data
S Malik, J Lally, O Ajnakina, M Pritchard, A Krivoy, F Gaughran, H Shetty, ...
Schizophrenia research 195, 267-273, 2018
Mandati: National Institute for Health Research, UK
Patterns of illness and care over the 5 years following onset of psychosis in different ethnic groups; the GAP-5 study
O Ajnakina, J Lally, M Di Forti, A Kolliakou, P Gardner-Sood, ...
Social psychiatry and psychiatric epidemiology 52, 1101-1111, 2017
Mandati: UK Medical Research Council, National Institute for Health Research, UK
Employment and relationship outcomes in first-episode psychosis: a systematic review and meta-analysis of longitudinal studies
O Ajnakina, B Stubbs, E Francis, F Gaughran, AS David, RM Murray, ...
Schizophrenia Research 231, 122-133, 2021
Mandati: US National Institutes of Health, UK Medical Research Council, National …
Lower bone mineral density at the hip and lumbar spine in people with psychosis versus controls: a comprehensive review and skeletal site-specific meta-analysis
L Gomez, B Stubbs, A Shirazi, D Vancampfort, F Gaughran, J Lally
Current Osteoporosis Reports 14, 249-259, 2016
Mandati: Research Foundation (Flanders), National Institute for Health Research, UK
Hyperprolactinaemia in first episode psychosis-A longitudinal assessment
J Lally, O Ajnakina, B Stubbs, HR Williams, M Colizzi, E Carra, S Fraietta, ...
Schizophrenia research 189, 117-125, 2017
Mandati: UK Medical Research Council, National Institute for Health Research, UK
Le informazioni sulla pubblicazione e sul finanziamento vengono stabilite automaticamente da un software